US5459268A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Xanthylium dyes that are well retained in mitochondria
Assignee: Molecular Probes Inc
•
Filing: 1993-10-25
•
Granted: 1995-10-17
•
Expires: 2013-10-25
Abstract
Abstract The dyes of the present invention are fluorescent substituted 3',6'-diaminoxanthenes and their reduced analogs 3',6'-diaminodihydroxanthenes, which are oxidized to the fluorescent form of the dye in situ. In their oxidized form, the dyes selectively localize within mitochondria. The dyes of the present invention include an alkylating group that is covalently attached that allows their retention in mitochondria even after cell death, fixation, and permeabilization.
Inventors
- 👤 Richard P. Haugland
- 👤 Mohammad N. Malekzadeh
- 👤 Yu-zhong Zhang
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 09:13
CPC Classifications
C; C09; C09B; C09B11/00; C09B11/04; C09B11/10; C09B11/12; C07; C07D; C07D311/00; C07D311/02; C07D311/78; C07D311/80; C07D311/82; C09B11/24
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
424 words
A compound of the formula ##STR13## or of the formula ##STR14## wherein a fused-ring system has ring substituents R 1 , R 4 , R 5 , and R 8 are independently H, Cl, Br, I, (CH 2 ) n CH 3 , or (CH 2 ) n CO 2 R 13 , where n is an integer from 0 to 15 and R 13 is an alkyl with 1-6 carbons; and amino substituents R 2 , R 3 , R 6 , and R 7 that are independently H or C 1 -C 6 alkyl; or optionally any ring substituent in combination with an adjacent amino substituent independently forms an additional fused ring such that R 1 in combination with R 2 , R 3 in combination with R 4 , R 5 in combination with R 6 , and R 7 in combination with R 8 is (CH 2 ) 3 or (CH 2 ) 2 ; Ω is a single covalent bond or Ω is --Z--Y--where Z is attached to the fused ring system, and Z is a covalent bond, or Z is (CH 2 ) i where i=1-6, or Z is ##STR15## where R 11 is a hydrocarbon chain with 1-6 carbons that is branched, unbranched, saturated or unsaturated; Y is a covalent bond or Y has the formula --OCH 2 R 12 --, --OR 13 --, --SR 12 --, --SR 13 --, --NHCOCH 2 R 12 --, --NHCOR 13 --, --CONHCH 2 R 12 --, --CONHR 13 --, --NHSO 2 R 12 --, --NHSO 2 R 13 --, --NHCONHCH 2 R 12 --, --NHCONHR 13 --, --NHCSNHCH 2 R 12 --, or --NHCSNHR 13 --, where R 12 is (CH 2 ) m and m=1-18, and R 13 is phenylene (--C 6 H 4 --); such that Z and Y are not both covalent bonds; A is an alkylating group that is CR 9 R 10 X, where R 9 and R 10 are independently H or CH 3 , and X is Cl, Br, I, or --OSO 2 R 16 , where R 16 is C 1 -C 6 alkyl; C 1 -C 6 perfluoroalkyl; or R 16 is phenyl, or phenyl substituted one or more times by C 1 -C 6 alkyl, C 1 -C 6 perfluoroalkyl, Cl, Br, I, NO 2 , or CN; or the alkylating group A is maleimidyl (--NC 4 H 2 O 2 ) or haloacetamido (--NH(C═O)--CH 2 ) where is Cl, Br or I; and Ψ is a biologically compatible counterion.
Claim 2
Dependent Claim
424 words
A compound of the formula ##STR13## or of the formula ##STR14## wherein a fused-ring system has ring substituents R 1 , R 4 , R 5 , and R 8 are independently H, Cl, Br, I, (CH 2 ) n CH 3 , or (CH 2 ) n CO 2 R 13 , where n is an integer from 0 to 15 and R 13 is an alkyl with 1-6 carbons; and amino substituents R 2 , R 3 , R 6 , and R 7 that are independently H or C 1 -C 6 alkyl; or optionally any ring substituent in combination with an adjacent amino substituent independently forms an additional fused ring such that R 1 in combination with R 2 , R 3 in combination with R 4 , R 5 in combination with R 6 , and R 7 in combination with R 8 is (CH 2 ) 3 or (CH 2 ) 2 ; Ω is a single covalent bond or Ω is --Z--Y--where Z is attached to the fused ring system, and Z is a covalent bond, or Z is (CH 2 ) i where i=1-6, or Z is ##STR15## where R 11 is a hydrocarbon chain with 1-6 carbons that is branched, unbranched, saturated or unsaturated; Y is a covalent bond or Y has the formula --OCH 2 R 12 --, --OR 13 --, --SR 12 --, --SR 13 --, --NHCOCH 2 R 12 --, --NHCOR 13 --, --CONHCH 2 R 12 --, --CONHR 13 --, --NHSO 2 R 12 --, --NHSO 2 R 13 --, --NHCONHCH 2 R 12 --, --NHCONHR 13 --, --NHCSNHCH 2 R 12 --, or --NHCSNHR 13 --, where R 12 is (CH 2 ) m and m=1-18, and R 13 is phenylene (--C 6 H 4 --); such that Z and Y are not both covalent bonds; A is an alkylating group that is CR 9 R 10 X, where R 9 and R 10 are independently H or CH 3 , and X is Cl, Br, I, or --OSO 2 R 16 , where R 16 is C 1 -C 6 alkyl; C 1 -C 6 perfluoroalkyl; or R 16 is phenyl, or phenyl substituted one or more times by C 1 -C 6 alkyl, C 1 -C 6 perfluoroalkyl, Cl, Br, I, NO 2 , or CN; or the alkylating group A is maleimidyl (--NC 4 H 2 O 2 ) or haloacetamido (--NH(C═O)--CH 2 ) where is Cl, Br or I; and Ψ is a biologically compatible counterion.
Claim 3
Dependent Claim
228 words
A compound according to claim 1 of the formula ##STR16## or of the formula ##STR17## wherein Ω is a single covalent bond or Ω is --Z--Y--where Z is attached to the fused ring system, and Z is a covalent bond, or Z is (CH 2 ) i where i=1-6, or Z is ##STR18## where R 11 is a hydrocarbon chain with 1-6 carbons that is branched, unbranched, saturated or unsaturated; Y is a covalent bond or Y has the formula --OCH 2 R 12 --, --OR 13 --, --SR 12 --. --SR 13 --, --NHCOCH 2 R 12 --, --NHCOR 13 --, --CONHCH 2 R 12 --, --CONHR 13 --, --NHSO 2 R 12 --, --NHSO 2 R 13 --, --NHCONHCH 2 R 12 --, --NHCONHR 13 --, --NHCSNHCH 2 R 12 --, or --NHCSNHR 13 --, where R 12 is (CH 2 ) m and m=1-18, and R 13 is phenylene (--C 6 H 4 --); such that Z and Y are not both covalent bonds; Ψ is a biologically compatible counterion; and X is Cl, Br, I, or --OSO 2 R 16 , where R 16 is C 1 -C 6 alkyl, C 1 -C 6 perfluoroalkyl; or R 16 is phenyl or phenyl substituted one or more times by C 1 -C 6 alkyl, C 1 -C 6 perfluoroalkyl, Cl, Br, I, NO or CN.
Claim 4
Dependent Claim
37 words
A compound of claim 2 wherein Ω is --Z--Y--, where Z is ##STR19## where R 11 is a hydrocarbon chain with 1-6 carbons that is branched, unbranched, saturated or unsaturated; and Y is a single covalent bond.
Claim 5
Dependent Claim
57 words
A compound of claim 2 wherein R 9 and R 10 are H, and X is Cl, Br, or --OSO 2 R 16 , where R 16 is C 1 -C 2 alkyl; C 1 -C 2 perfluoroalkyl; phenyl; or phenyl substituted one or more times by C 1 -C 2 alkyl, C 1 -C 2 perfluoroalkyl.
Claim 6
Dependent Claim
83 words
A compound of claim 2 wherein R 1 , R 4 , R 5 , and R 8 are H and R 2 , R 3 , R 6 , and R 7 are independently H, CH 3 or C 2 H 5 ; or R 1 in combination with R 2 , R 4 in combination with R 4 , R 5 in combination with R 6 , and R 7 in combination with R 8 are (CH 2 ) 3 .
Claim 7
Dependent Claim
166 words
A compound according to claim 2, of the formula ##STR20## or of the formula ##STR21## wherein R 1 , R 4 , R 5 , and R 8 are H; and R 2 , R 3 , R 6 , and R 7 are H, CH 3 , C 2 H 5 ; or R 1 in combination with R 2 , R 4 in combination with R 4 , R 5 in combination with R 6 , and R 7 in combination with R 8 are (CH 2 ) 3 ; and R 15 is H or --CO 2 R 11 , where R 11 is a hydrocarbon chain with 1-6 carbons that is branched, unbranched, saturated or unsaturated; and X is Cl, Br, I, or --OSO 2 R 16 , where R 16 is C 1 -C 2 alkyl; C 1 -C 2 perfluoroalkyl; phenyl; or phenyl substituted one or more times by C 1 -C 2 alkyl or C 1 -C 2 perfluoroalkyl.
Claim 8
Dependent Claim
30 words
A compound of claim 6, wherein R 2 , R 3 , R 6 , and R 7 are CH 3 ; R 15 is H; and X is Cl.
Claim 9
Dependent Claim
14 words
A compound of claim 6 of the formula ##STR22## or of the formula ##STR23##
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-10-16 | 1999-04-17 | 1999-10-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-10-16 | 2003-04-17 | 2003-10-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-10-16 | 2007-04-17 | 2007-10-17 | $7700.00 | Window Closed / Lapsed |